Françoise Dignat-George

Professor, Director at C2VN
Aix-Marseille University

Françoise Dignat-George has a long-standing expertise on Vascular Biology, Hemostasis, Inflammation and Angiogenesis, with a great interest in Patient oriented/translational applications. The general objective is to understand the cellular and molecular control of endothelial dynamics in interaction with its environment and its dysregulation in vascular disorders, in order to identify news pathways and emergent therapeutic / diagnostic targets. This research strategy has been involved in developing the concept of “personalized vascular-targeted medicine”.
She is the author of 485 papers, 13 patents and 2 licenses in the field of Vascular Biology and Hemostasis. From 2010 to 2014, she was President of the SSC Scientific Subcommittee on Vascular Biology and member of the Scientific Council of the International Society of Thrombosis and Haemostasis .

Presentation(s):

• OC 18.1 - Therapeutic potential of CD146 extracellular vesicles for the treatment of atherosclerosis

  Sunday, July 10, 2022
  10:45 AM – 11:00 AM

• VPB0109 - NLRP3 inflammasome activation and immunothrombosis in COVID-19.

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 32.5 - CD146-positive tumors are associated with venous thromboembolism

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• SOA 27.1 - Microparticle Driven Fibrinolysis: Role in Septic Choc

  Wednesday, July 13, 2022
  8:30 AM – 8:50 AM